LSE:OKYO - OKYO Pharma Limited OKYO Pharma Limited
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

GBX 4.05    -0.450 (-10%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Sep 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Gary S. Jacob Ph.D.

Headquarters: UK

Employees: 6

Homepage

Description

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.